Benelux countries approve Iluvien for noninfectious posterior uveitis

Iluvien has been approved by the governmental agencies overseeing medical products in Belgium, the Netherlands and Luxemburg, Alimera Sciences announced in a press release.
The marketing authorization allows Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg), a sustained-release intravitreal implant that uses continuous microdosing technology, to be used to reduce the recurrence of noninfectious posterior uveitis affecting the posterior segment of the eye.
“We are pleased to now have the approvals for this new indication for Iluvien across Benelux so that our partner, Horus

Full Story →